Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Cumberland Pharmaceuticals Inc. CPIX

Set alert

Price alert · CPIX

All alert types
4.44 USD -0.25 -5.33%

As of Nov 2, 10:46 AM ET

Bid
4.37 × 2
Ask
4.53 × 1
4.30 Day range 4.67
1.85 52-week range 9.28
YTD
+11.56%
1 year
+48.49%
Open
4.64
Prev close
4.69
Mkt cap
67.12M
Vol
76.77K
Avg vol
84.40K
EPS
-0.62
P/E
0.00
Div yield
0.00%
More statistics
Low
4.30
High
4.67
Forward P/E
16.07
Beta
0.22
Short ratio
0.92
Inst. own
14.69%
Dividend
0.00
Ex-div date
50-d avg
1.40
200-d avg
1.48
1y target
0.00

1D chart

Chart tools
Interval
1m5m15m30m

Signals (8)
NameTimeAgo
RSI: Overbought3:57 PM2 days ago
MACD: Buy Signal3:56 PM2 days ago
MACD: Sell Signal3:53 PM2 days ago
MACD: Buy Signal3:52 PM2 days ago
SMA: Bullish3:47 PM2 days ago
SMA: Bearish3:44 PM2 days ago
MACD: Sell Signal3:43 PM2 days ago
MACD: Buy Signal3:42 PM2 days ago

Financial health

Altman Z-Score

0.13 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 1

Valuation

P/E -20.9×
FY 2016: -91.7×FY 2017: -14.7×FY 2018: -13.4×FY 2019: -22.4×FY 2020: -13.4×FY 2021: -19.5×FY 2022: -5.9×FY 2023: -4.1×FY 2024: -5.2×FY 2025: -20.9×
FY 2016 5y median -5.9× FY 2025
P/S 1.3×
FY 2016: 2.6×FY 2017: 2.8×FY 2018: 2.3×FY 2019: 2.3×FY 2020: 1.2×FY 2021: 1.9×FY 2022: 0.8×FY 2023: 0.6×FY 2024: 0.9×FY 2025: 1.3×
FY 2016 5y median 0.9× FY 2025
P/B 2.4×
FY 2016: 1.2×FY 2017: 1.8×FY 2018: 1.7×FY 2019: 1.6×FY 2020: 1.0×FY 2021: 1.6×FY 2022: 0.9×FY 2023: 0.9×FY 2024: 1.5×FY 2025: 2.4×
FY 2016 5y median 1.5× FY 2025
P/FCF 12.3×
FY 2016: -55.5×FY 2017: -57.2×FY 2018: -80.8×FY 2019: 28.2×FY 2020: 13.5×FY 2021: 11.6×FY 2022: 5.1×FY 2023: 4.5×FY 2024: -42.1×FY 2025: 12.3×
FY 2016 5y median 5.1× FY 2025
EV/EBITDA 19.7×
FY 2016: 48.1×FY 2017: -71.8×FY 2018: -10.5×FY 2019: -15.6×FY 2020: -25.2×FY 2021: -68.3×FY 2022: 102×FY 2023: 168×FY 2024: 197×FY 2025: 19.7×
FY 2016 5y median 102× FY 2025
EV/Sales 1.3×
FY 2016: 1.7×FY 2017: 2.0×FY 2018: 2.1×FY 2019: 2.1×FY 2020: 1.0×FY 2021: 1.6×FY 2022: 0.8×FY 2023: 0.6×FY 2024: 0.9×FY 2025: 1.3×
FY 2016 5y median 0.9× FY 2025
FCF Yield 8.1%
FY 2016: -1.8%FY 2017: -1.7%FY 2018: -1.2%FY 2019: 3.5%FY 2020: 7.4%FY 2021: 8.6%FY 2022: 19.5%FY 2023: 22.0%FY 2024: -2.4%FY 2025: 8.1%
FY 2016 5y median 8.6% FY 2025

Profitability

Gross Margin 85.0%
FY 2016: 82.0%FY 2017: 82.1%FY 2018: 81.9%FY 2019: 78.4%FY 2020: 76.9%FY 2021: 75.5%FY 2022: 78.3%FY 2023: 84.7%FY 2024: 82.6%FY 2025: 85.0%
FY 2016 5y median 82.6% FY 2025
Operating Margin -6.3%
FY 2016: -4.3%FY 2017: -9.9%FY 2018: -18.1%FY 2019: -27.0%FY 2020: -17.0%FY 2021: -21.3%FY 2022: -13.6%FY 2023: -24.2%FY 2024: -17.0%FY 2025: -6.3%
FY 2016 5y median -17.0% FY 2025
Net Margin -6.4%
FY 2016: -2.9%FY 2017: -19.4%FY 2018: -17.1%FY 2019: -10.3%FY 2020: -8.9%FY 2021: -9.7%FY 2022: -13.3%FY 2023: -15.9%FY 2024: -17.1%FY 2025: -6.4%
FY 2016 5y median -13.3% FY 2025
ROE -11.4%
FY 2016: -1.3%FY 2017: -12.4%FY 2018: -12.5%FY 2019: -6.9%FY 2020: -7.1%FY 2021: -8.2%FY 2022: -15.4%FY 2023: -21.2%FY 2024: -28.4%FY 2025: -11.4%
FY 2016 5y median -15.4% FY 2025
ROIC -6.9%
FY 2016: -1.4%FY 2017: -5.4%FY 2018: -8.7%FY 2019: -11.3%FY 2020: -8.6%FY 2021: -11.6%FY 2022: -8.8%FY 2023: -17.6%FY 2024: -13.0%FY 2025: -6.9%
FY 2016 5y median -11.6% FY 2025
ROA -3.7%
FY 2016: -1.0%FY 2017: -8.6%FY 2018: -6.2%FY 2019: -3.4%FY 2020: -3.5%FY 2021: -4.2%FY 2022: -6.0%FY 2023: -7.7%FY 2024: -8.6%FY 2025: -3.7%
FY 2016 5y median -6.0% FY 2025

Growth (YoY)

Revenue 17.6%
FY 2016: -1.5%FY 2017: 24.6%FY 2018: -1.0%FY 2019: -15.6%FY 2020: 8.9%FY 2021: -3.9%FY 2022: 16.7%FY 2023: -5.9%FY 2024: -4.3%FY 2025: 17.6%
FY 2016 FY 2025
Operating Income 56.6%
FY 2016: -28.9%FY 2017: -184.8%FY 2018: -81.1%FY 2019: -25.7%FY 2020: 31.3%FY 2021: -20.3%FY 2022: 25.7%FY 2023: -67.5%FY 2024: 32.7%FY 2025: 56.6%
FY 2016 FY 2025
EPS (diluted) 58.7%
FY 2016: -245.5%FY 2017: -759.1%FY 2018: 10.0%FY 2019: 48.9%FY 2020: 4.3%FY 2021: -9.1%FY 2022: -58.3%FY 2023: -15.8%FY 2024: -4.5%FY 2025: 58.7%
FY 2016 FY 2025
Free Cash Flow 710.5%
FY 2016: -149.1%FY 2017: -31.1%FY 2018: 43.2%FY 2019: 341.8%FY 2020: 17.5%FY 2021: 81.4%FY 2022: 6.5%FY 2023: -11.6%FY 2024: -114.0%FY 2025: 710.5%
FY 2016 FY 2025

Financial Health

Current Ratio 1.0×
FY 2016: 4.4×FY 2017: 3.9×FY 2018: 2.7×FY 2019: 2.1×FY 2020: 1.9×FY 2021: 2.4×FY 2022: 1.6×FY 2023: 1.3×FY 2024: 1.2×FY 2025: 1.0×
FY 2016 5y median 1.3× FY 2025
Quick Ratio 0.8×
FY 2016: 4.1×FY 2017: 3.5×FY 2018: 1.7×FY 2019: 1.7×FY 2020: 1.5×FY 2021: 1.9×FY 2022: 1.3×FY 2023: 1.1×FY 2024: 1.0×FY 2025: 0.8×
FY 2016 5y median 1.1× FY 2025
Debt / Equity 0.4×
FY 2016: 0.1×FY 2017: 0.2×FY 2018: 0.4×FY 2019: 0.4×FY 2020: 0.4×FY 2021: 0.4×FY 2022: 0.6×FY 2023: 0.6×FY 2024: 0.9×FY 2025: 0.4×
FY 2016 5y median 0.6× FY 2025
Net Debt / EBITDA -0.4×
FY 2016: -26.0×FY 2017: 31.4×FY 2018: 1.0×FY 2019: 1.4×FY 2020: 3.5×FY 2021: 12.8×FY 2022: 3.6×FY 2023: 0.7×FY 2024: 14.3×FY 2025: -0.4×
FY 2016 5y median 3.6× FY 2025
Interest Coverage -5.6×
FY 2016: -13.5×FY 2017: -43.9×FY 2018: -37.7×FY 2019: -37.7×FY 2020: -24.2×FY 2021: -78.3×FY 2022: -9.7×FY 2023: -14.3×FY 2024: -10.6×FY 2025: -5.6×
FY 2016 5y median -10.6× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31